Blood biomarkers for 8 diseases
How MindX finds blood biomarkers for eight indications: depression and bipolar, anxiety, PTSD, psychosis (schizophrenia), suicidality, pain, Alzheimer's, and longevity.

MindX Sciences offers blood-based mental health testing that reads gene activity to guide treatment.
mindxsciences.comCrawled Nov 14, 2026
How MindX finds blood biomarkers for eight indications: depression and bipolar, anxiety, PTSD, psychosis (schizophrenia), suicidality, pain, Alzheimer's, and longevity.
MindX One packages tests for 8 diseases into one blood draw: depression and bipolar, anxiety, PTSD, psychosis (schizophrenia), suicidality, pain, Alzheimer's, and longevity. Each report ranks treatment matches.
Order MindX One for your patients: one blood test with reports for depression, bipolar, anxiety, PTSD, psychosis, suicidality, pain, and Alzheimer's.
A worked example of MindX One for a college student referred for anxiety, panic attacks, and trouble sleeping.
MindX One XC is one blood draw with reports for depression and bipolar, anxiety, PTSD, psychosis (schizophrenia), suicidality, pain, Alzheimer's, and longevity, plus medication and nutraceutical matching.
MindX Sciences sells apparel and accessories.
Happiness. A MindX Sciences newsletter on precision psychiatry and the MindX One blood test.
MindX One tests eight diseases from one blood draw: depression and bipolar, anxiety, PTSD, psychosis (schizophrenia), suicidality, pain, memory, and longevity.
Lectures on precision medicine for psychiatry and pain, including the MindX One blood test for psychosis, mood, PTSD, and the other disease reports.
Mood. A MindX Sciences newsletter on precision psychiatry and the MindX One blood test.
Peer-reviewed papers behind MindX One, the blood test with reports for mood, anxiety, PTSD, psychosis, suicidality, pain, memory, and longevity.
Suicidality. A MindX Sciences newsletter on precision psychiatry and the MindX One blood test.
News about MindX Sciences and MindX One, the blood test with reports for depression, anxiety, PTSD, psychosis, and more.
Jozy Altidore, Bobby Wood, and Eriq Zavaleta invest in MindX Sciences and objective mental health blood testing for athletes.
DNA tests read inherited genes. MindX One measures RNA activity in one blood test for depression, bipolar, anxiety, PTSD, psychosis, suicidality, pain, Alzheimer's, and longevity.
The clinicians and scientists behind MindX One, one blood test with reports for eight diseases.
Alexander B. Niculescu, MD, PhD, on the science behind MindX One: RNA blood biomarkers for eight diseases, not inherited DNA.
CLIA certification, state licensure, and how accurate the MindX One blood test is across its eight disease reports.
Issued patents on blood tests for depression, bipolar, PTSD, psychosis, pain, memory, and matching people to treatments.
MindX One blood testing and Life x Improve for elite performers who want objective data on mood, stress, PTSD, and mental functioning.
Contact MindX Sciences about the MindX One blood test. Offices in Indianapolis and at Mayo Clinic Discovery Oasis in Phoenix.
Precision Psychiatry. Personalized Mental Health.
Life x Mind stores user history on the device and does not share, analyze, or sell it.
MindX Sciences Privacy Policy
MindX Sciences Terms of Service and End-User License Agreement
Precision psychiatry shifts from generic treatment models to tailored approaches using biologic measures for individualized psychiatric care. This method aims to replace trial-and-error practices with objective assessments to determine optimal therapies. The field leverages biological data to refine treatment strategies for mental health conditions.
Indiana University researchers create a blood-based gene expression test that identifies biomarkers linked to severe schizophrenia symptoms, including high hallucination and delusion states. The test also predicts future hospitalizations for patients. The approach leverages molecular diagnostics to analyze genetic activity in blood samples.
Researchers develop a blood test that identifies schizophrenia risk and guides treatment selection for patients with the disorder. The test aims to improve early intervention by detecting biomarkers linked to symptoms like delusions and hallucinations. Scientists highlight its potential to personalize therapy approaches based on individual biological profiles.
MindX Sciences partners with Q2 Solutions to integrate whole-transcriptome RNA analysis into psychiatric blood tests. The collaboration offers physicians early access to objective biomarkers for diagnosing psychiatric disorders. The test leverages RNA expression markers to improve diagnostic accuracy beyond traditional methods.
Indy-based scientists and pharma leaders develop a blood test to detect biological markers for suicide risk, PTSD, and depression. The test aims to provide measurable evidence of mental health conditions, potentially transforming prevention and treatment approaches. The project operates from a 10th Street office park in Indianapolis.